Beyond 75: Graft Allocation and Organ Utility Implications in Liver Transplantation.

IF 1.9 Q3 TRANSPLANTATION Transplantation Direct Pub Date : 2024-09-26 eCollection Date: 2024-10-01 DOI:10.1097/TXD.0000000000001661
Miho Akabane, Allison Kwong, Yuki Imaoka, Carlos O Esquivel, W Ray Kim, Marc L Melcher, Kazunari Sasaki
{"title":"Beyond 75: Graft Allocation and Organ Utility Implications in Liver Transplantation.","authors":"Miho Akabane, Allison Kwong, Yuki Imaoka, Carlos O Esquivel, W Ray Kim, Marc L Melcher, Kazunari Sasaki","doi":"10.1097/TXD.0000000000001661","DOIUrl":null,"url":null,"abstract":"<p><strong>Background: </strong>The global surge in aging has intensified debates on liver transplantation (LT) for candidates aged 75 y and older, given the prevalent donor scarcity. This study examined both the survival benefits and organ utility of LT for this age group.</p><p><strong>Methods: </strong>A total of 178 469 adult LT candidates from the United Network for Organ Sharing database (2003-2022) were analyzed, with 112 266 undergoing LT. Post-LT survival outcomes and waitlist dropout rates were monitored across varying age brackets. Multivariable Cox regression analysis determined prognostic indicators. The 5-y survival benefit was assessed by comparing LT recipients to waitlist candidates using hazard ratios. Organ utility was evaluated through a simulation model across various donor classifications.</p><p><strong>Results: </strong>Among candidates aged 75 y and older, 343 received LT. The 90-d graft and patient survival rates for these patients were comparable with those in other age categories; however, differences emerged at 1 and 3 y. Age of 75 y or older was identified as a significant negative prognostic indicator for 3-y graft survival (hazard ratio: 1.72 [1.20-2.42], <i>P</i> < 0.01). Dropout rates for the 75 y and older age category were 12.0%, 24.1%, and 35.1% at 90 d, 1 y, and 3 y, respectively. The survival benefit of LT for the 75 y and older cohort was clear when comparing outcomes between LT recipients and those on waitlists. However, organ utility considerations did not favor allocating livers to this age group, regardless of donor type. Comparing 3-y patient survival between LT using donors aged 60 y and younger and older than 60 y showed no significant difference (<i>P</i> = 0.50) in the 75 y or older cohort.</p><p><strong>Conclusions: </strong>Although LT offers survival benefits to individuals aged 75 y and older, the system may need rethinking to optimize the use of scarce donor livers, perhaps by matching older donors with older recipients.</p>","PeriodicalId":23225,"journal":{"name":"Transplantation Direct","volume":null,"pages":null},"PeriodicalIF":1.9000,"publicationDate":"2024-09-26","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11446594/pdf/","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Transplantation Direct","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.1097/TXD.0000000000001661","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"2024/10/1 0:00:00","PubModel":"eCollection","JCR":"Q3","JCRName":"TRANSPLANTATION","Score":null,"Total":0}
引用次数: 0

Abstract

Background: The global surge in aging has intensified debates on liver transplantation (LT) for candidates aged 75 y and older, given the prevalent donor scarcity. This study examined both the survival benefits and organ utility of LT for this age group.

Methods: A total of 178 469 adult LT candidates from the United Network for Organ Sharing database (2003-2022) were analyzed, with 112 266 undergoing LT. Post-LT survival outcomes and waitlist dropout rates were monitored across varying age brackets. Multivariable Cox regression analysis determined prognostic indicators. The 5-y survival benefit was assessed by comparing LT recipients to waitlist candidates using hazard ratios. Organ utility was evaluated through a simulation model across various donor classifications.

Results: Among candidates aged 75 y and older, 343 received LT. The 90-d graft and patient survival rates for these patients were comparable with those in other age categories; however, differences emerged at 1 and 3 y. Age of 75 y or older was identified as a significant negative prognostic indicator for 3-y graft survival (hazard ratio: 1.72 [1.20-2.42], P < 0.01). Dropout rates for the 75 y and older age category were 12.0%, 24.1%, and 35.1% at 90 d, 1 y, and 3 y, respectively. The survival benefit of LT for the 75 y and older cohort was clear when comparing outcomes between LT recipients and those on waitlists. However, organ utility considerations did not favor allocating livers to this age group, regardless of donor type. Comparing 3-y patient survival between LT using donors aged 60 y and younger and older than 60 y showed no significant difference (P = 0.50) in the 75 y or older cohort.

Conclusions: Although LT offers survival benefits to individuals aged 75 y and older, the system may need rethinking to optimize the use of scarce donor livers, perhaps by matching older donors with older recipients.

查看原文
分享 分享
微信好友 朋友圈 QQ好友 复制链接
本刊更多论文
超越 75 岁:肝移植中的移植物分配和器官效用影响。
背景:鉴于供体普遍稀缺,全球老龄化的激增加剧了对75岁及以上患者进行肝移植(LT)的讨论。本研究探讨了肝移植对这一年龄组的生存益处和器官效用:分析了器官共享联合网络数据库(2003-2022 年)中的 178 469 名成人 LT 候选者,其中 112 266 人接受了 LT。对不同年龄段的LT术后生存结果和等待者退出率进行了监测。多变量考克斯回归分析确定了预后指标。通过比较LT接受者和候选者的危险比,评估了5年生存率的益处。通过模拟模型对不同供体分类的器官效用进行了评估:结果:在 75 岁及以上的候选者中,有 343 人接受了 LT。这些患者的 90 天移植物存活率和患者存活率与其他年龄段的患者相当;但在 1 年和 3 年时出现了差异。在 75 岁或以上的人群中,75 岁或以上的年龄被确定为 3 年移植物存活率的一个重要负面预后指标(危险比:1.72 [1.20-2.42],P P = 0.50):尽管LT能为75岁及以上的患者带来生存益处,但可能需要重新考虑该系统,以优化稀缺供体肝脏的使用,或许可以将年长的供体与年长的受体相匹配。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 去求助
来源期刊
Transplantation Direct
Transplantation Direct TRANSPLANTATION-
CiteScore
3.40
自引率
4.30%
发文量
193
审稿时长
8 weeks
期刊最新文献
Beyond 75: Graft Allocation and Organ Utility Implications in Liver Transplantation. Clinical Translation and Implementation of a Bioartificial Pancreas Therapy: A Qualitative Study Exploring the Perspectives of People With Type 1 Diabetes. Making Living-donor Liver Transplantation a Viable Option for Patients With Portopulmonary Hypertension. Outcomes of Older Primary Kidney Transplant Recipients by Induction Agent and High-risk Viral Discordance Status in the United States. Molecular Signature Associated With Acute Rejection in Vascularized Composite Allotransplantation.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
已复制链接
已复制链接
快去分享给好友吧!
我知道了
×
扫码分享
扫码分享
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1